Chul Kim (@chulkimmd) 's Twitter Profile
Chul Kim

@chulkimmd

Thoracic Medical Oncologist at Georgetown University | Lung Cancer & Thymic Epithelial Tumors | Father/husband/immigrant | #SoMeEditor @ClinicalLung | #LCSM

ID: 830044361979224064

calendar_today10-02-2017 13:22:52

2,2K Tweet

3,3K Followers

776 Following

Chul Kim (@chulkimmd) 's Twitter Profile Photo
Chul Kim
@chulkimmd

8 days ago

The approval of afamitresgene autoleucel (afami-cel), a TCR therapy for HLA-A*02 and MAGE-A4-expressing synovial sarcoma, highlights the potential for further development of TCR-based therapies in solid tumors. PRAME is another important target for TCR therapy. #ASCO25

The approval of afamitresgene autoleucel (afami-cel), a TCR therapy for HLA-A*02 and MAGE-A4-expressing synovial sarcoma, highlights the potential for further development of TCR-based therapies in solid tumors. PRAME is another important target for TCR therapy. #ASCO25